Johns Hopkins Hospital
Baltimore, Maryland, 21287, United States
Location status: Recruiting
NCT Number: NCT06135870
The investigators are evaluating the role of senescent cells in uterine fibroids.
Interested in participating?
Request Info18 year–55 year
Female
Observational
Baltimore, Maryland, 21287, United States
Location status: Recruiting
Uterine fibroids are prevalent tumors of uterus characterized by excessive fibrotic tissues. Using new cutting-edge computational methods, the investigators have found that small groups of senescent cells in fibroids work in concert with immune cells to produce soluble factors in fibroid tissues to create a feed-forward loop leading to fibrosis. This project seeks to unravel key cell-cell communication networks involving senescent and immune cells in fibroids to develop new treatments for uterine fibroids.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 5 years
Perform scRNASeq on human fibroids and control myometrium tissue and apply transfer learning algorithm for SnC identification and phenotyping to identify cell-cell communication patterns in fibroids versus control myometrial tissue using Domino to validate computationally predicted senescent cell types. The computationally predicted immune phenotypes will be validated with flow cytometry.
Time frame: 5 years
Quantify levels of transcripts and proteins in the fibroid senescence-associated secretory profile (SASP) using ELISA and western blotting techniques
Time frame: 5 years
Examine the in-vitro effects of senotherapeutcis using leiomyoma culture models and in mouse models. Measured by inhibition of proliferation, induction of apoptosis, inhibition ECM deposition, decrease in SnCs (senolytics) and senescence-associated secretory profile SASPs (senomorphics).
Contact information is provided by the study sponsor or research team.
Bhuchitra Singh, MD, MPH, MBA
CONTACT
James Segars, MD
CONTACT
Johns Hopkins University
Other
Role of Senescent Cells in Uterine Fibroid Pathogenesis
Acronym: SOUL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06143631
Fibroid, Fibroid Uterus
Los Angeles, California, United States
View Trial DetailsNCT03323905
Fibroid, Leiomyoma
Toronto, Ontario, Canada
View Trial DetailsNCT00891657
Cicatrix, Fibroid
Oldenburg, Germany
View Trial DetailsNCT00746031
Fibroid, Leiomyoma
Edinburgh, United Kingdom
View Trial Details